Bio-Techne (TECH) EBT Margin (2016 - 2025)
Historic EBT Margin for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 17.16%.
- Bio-Techne's EBT Margin rose 27300.0% to 17.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 9.39%, marking a year-over-year decrease of 61400.0%. This contributed to the annual value of 8.07% for FY2025, which is 79500.0% down from last year.
- Bio-Techne's EBT Margin amounted to 17.16% in Q4 2025, which was up 27300.0% from 16.75% recorded in Q3 2025.
- In the past 5 years, Bio-Techne's EBT Margin ranged from a high of 5185.8% in Q3 2022 and a low of 7.21% during Q2 2025
- Over the past 5 years, Bio-Techne's median EBT Margin value was 18.26% (recorded in 2021), while the average stood at 276.42%.
- Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 51596500bps in 2022, then crashed by -51679000bps in 2023.
- Over the past 5 years, Bio-Techne's EBT Margin (Quarter) stood at 32.0% in 2021, then decreased by -24bps to 24.46% in 2022, then tumbled by -50bps to 12.25% in 2023, then rose by 18bps to 14.43% in 2024, then increased by 19bps to 17.16% in 2025.
- Its EBT Margin stands at 17.16% for Q4 2025, versus 16.75% for Q3 2025 and 7.21% for Q2 2025.